CTSO today
$4.80+$0.18 (+3.90%)close Nov 6, 2026Trend
DailyUptrend (starting)
4 hourLeaning Bullish
1 hourStrong Bullish
15 minExpanding
5 minStrong Bearish
Daily trend turns down below $2.84
Key levels
Resistance$6.96
Resistance$5.42
Support$3.76
Support$2.84
Latest news & SEC filings
AnalystWBB Securities starts CytoSorbents coverage with Speculative Buy, $9.50 target
AnalystWBB Securities starts CytoSorbents coverage with Speculative Buy, $9.5 target
All CTSO news →About CytoSorbents
CytoSorbents makes blood purification devices that use porous polymer beads to capture toxins and inflammatory substances from blood. Its main product, CytoSorb, is a cartridge used with standard hospital blood pumps in intensive care and cardiac surgery, and holds regulatory clearance across Europe and is sold in many countries. The company also offers ECOS-300CY for organ perfusion, VetResQ for veterinary use, and the PuriFi hemoperfusion pump. It is developing DrugSorb-ATR for heart surgery patients in the United States and Canada.
Based on the company's 10-K filed Mar 30, 2026.
Nasdaq · Healthcare
Cytosorbents Corp (CTSO)
What Is the Price Target for CTSO?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is CTSO a Buy or Sell Right Now?
Thesis
- •Revenue growing 4.1% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for CTSO.
Start Free Trial →Is CTSO Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/B
Fair Value
$0.63
33
Moat Score
NONE
3/9
Piotroski Score
-6.9
Altman Z-Score
What Is Smart Money Doing with CTSO?
Insider Signal
NEUTRAL
2 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Chan Phillip P. | director officer | Buy | 10,333 | $4K | Jun 15, 2026 |
| Chan Phillip P. | director officer | Buy | 251,136 | $100K | Jun 12, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →CTSO Growth Story
Revenue YoY
4.1%
3yr Revenue CAGR
2.2%
EPS Growth YoY
65.79%
FCF Growth YoY
14.8%
Revenue Trend
ACCELERATING
Dark Pool Trades for CTSO
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for CTSO, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 15:35:08 | $4.50 | 4,918 | $$22K | SELL |
| 15:28:02 | $4.28 | 5,000 | $$21K | SELL |
| 15:24:34 | $4.53 | 2,002 | $$9K | SELL |
| 15:23:18 | $4.28 | 2,000 | $$9K | SELL |
| 18:43:42 | $4.65 | 1,000 | $$5K | BUY |
5 dark pool trades shown · $$66K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Cytosorbents Corp (CTSO) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings intelligence, and a complete investment thesis with entry and exit recommendations.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →CTSO — frequently asked questions
What is CTSO stock price today?
Cytosorbents Corp (CTSO) is at $4.80, up 3.90% (+$0.18) at the Nov 6, 2026 close.
Why is CTSO stock moving today?
Latest CTSO news — Oct 22, 2026: WBB Securities starts CytoSorbents coverage with Speculative Buy, $9.50 target · Oct 21, 2026: WBB Securities starts CytoSorbents coverage with Speculative Buy, $9.5 target
Did CTSO beat earnings?
CTSO last reported on Aug 6, 2026: EPS -$1.40 vs -$0.80 expected — a miss of 75.0%.
How much debt does CTSO have?
Cytosorbents Corp reported $17M of debt and $4M of cash (Jun 30, 2026).
What are CTSO support and resistance levels?
Support: $3.76, $2.84. Resistance: $5.42, $6.96, $15.22.
What are insiders doing with CTSO?
Insider activity: NEUTRAL, 2 buys and 0 sells in the last 90 days.
What is the latest news on CTSO?
Oct 22, 2026: WBB Securities starts CytoSorbents coverage with Speculative Buy, $9.50 target · Oct 21, 2026: WBB Securities starts CytoSorbents coverage with Speculative Buy, $9.5 target